We are live on ! Find out more
KURA icon

Kura Oncology
KURA

76 hedge funds and large institutions have $299M invested in Kura Oncology in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 6

150% more call options, than puts

Call options by funds: $5K | Put options by funds: $2K

15% more funds holding

Funds holding: 66 → 76 (+10)

13% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 23

3% more capital invested

Capital invested by funds: $290M → $299M (+$8.64M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

5.48% less ownership

Funds ownership: 70.13% → 64.64% (-5.5%)

Holders
76
Holders Change
+10
Holders Change %
+15.15%
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
16
Increased
26
Reduced
23
Closed
6
Calls
$5K
Puts
$2K
Net Calls
+$3K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.4M
2
GPP
Great Point Partners
Connecticut
+$6.58M
3
Morgan Stanley
Morgan Stanley
New York
+$2.97M
4
NC
Nexthera Capital
New York
+$2.76M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$9.72M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.45M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$5.79M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.61M
5
Deutsche Bank
Deutsche Bank
Germany
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
EGI
26
EAM Global Investors
California
$1.17M +$1.12M +76,300 New
BCM
27
Bridgeway Capital Management
Texas
$1.03M -$368K -25,000 -27%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.02M +$113K +7,655 +13%
SH
29
Sandia Holdings
Connecticut
$922K +$888K +60,240 New
AGA
30
Altrinsic Global Advisors
Connecticut
$918K – – –
Deutsche Bank
31
Deutsche Bank
Germany
$819K -$2.14M -145,345 -73%
PVI
32
Pura Vida Investments
New York
$765K +$737K +50,000 New
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$752K +$378K +25,667 +109%
TCIM
34
TIAA CREF Investment Management
New York
$728K +$13.5K +915 +2%
Charles Schwab
35
Charles Schwab
California
$627K +$26.1K +1,774 +5%
TA
36
Teachers Advisors
New York
$579K +$192K +13,050 +53%
Wells Fargo
37
Wells Fargo
California
$537K +$424K +28,777 +455%
Lazard Asset Management
38
Lazard Asset Management
New York
$536K +$517K +35,069 New
B
39
Bailard
California
$517K +$498K +33,805 New
OAM
40
Oxford Asset Management
United Kingdom
$516K +$501K +33,966 New
AA
41
ALPS Advisors
Colorado
$512K +$493K +33,483 New
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$486K +$3.89K +264 +0.8%
PPCM
43
Pillar Pacific Capital Management
California
$457K -$9.58K -650 -2%
JMPWA
44
JP Morgan Private Wealth Advisors
California
$451K – – –
Goldman Sachs
45
Goldman Sachs
New York
$447K +$141K +9,590 +49%
VEA
46
Virtus ETF Advisers
New York
$392K +$378K +25,648 New
VFA
47
Virtus Fund Advisers
Connecticut
$392K +$378K +25,648 New
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$340K +$72.2K +4,900 +28%
ProShare Advisors
49
ProShare Advisors
Maryland
$295K +$284K +19,270 New
PIM
50
Partner Investment Management
California
$284K -$105K -7,127 -28%
1
2
3 4

KURA Hedge Fund Activity: Q4 2017 in Review

76 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2017, worth a combined $299M — up 3% from $290M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KURA positions and 6 closed out — a net gain of 10 holders — while 26 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $7.4M. The largest seller was PFM Health Sciences, cutting an estimated $9.72M.

  • 76 institutional investors held Kura Oncology (KURA) as of Q4 2017, up from 66 in Q3 2017.
  • Funds reported $299M of Kura Oncology stock for Q4 2017, up 3% quarter-over-quarter.
  • 16 funds opened new Kura Oncology positions in Q4 2017 and 6 closed out, a net change of +10 holders.
  • The largest Kura Oncology buyer in Q4 2017 was BlackRock, an estimated $7.4M added.
  • The largest Kura Oncology seller in Q4 2017 was PFM Health Sciences, an estimated $9.72M sold.

Based on aggregated 13F filings for Q4 2017.